research use only

Claudin-5 Antibody [F16P13]

Cat.No.: F5914

    Application: Reactivity:
    • F5914-wb
      Lane 1: HUVEC, Lane 2: Mouse lung

    Usage Information

    Dilution
    1:1000
    1:200
    1:1600-1:6400
    Application
    WB, IP, IF
    Reactivity
    Human, Mouse
    Source
    Rabbit Monoclonal Antibody
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    23 kDa

    Datasheet & SDS

    Biological Description

    Specificity
    Claudin-5 Antibody [F16P13] detects endogenous levels of total Claudin-5 protein.
    Clone
    F16P13
    Synonym(s)
    Claudin-5; CLDN5
    Background
    Claudin‑5 is a tetraspanin integral membrane protein belonging to the claudin family of tight‑junction components that forms selective paracellular barriers in endothelial and epithelial tissues, with particularly high expression in the brain microvasculature and lung. Claudin‑5 contains four membrane‑spanning domains and two extracellular loops that form continuous sealing strands between adjacent cells, and its short intracellular termini interact with tight‑junction plaque proteins such as ZO‑1 to couple the junction to the actin cytoskeleton and stabilize cell‑cell contact. Claudin‑5 is the most enriched claudin isoform and functions as a size‑selective molecular sieve that tightly restricts paracellular flux of small hydrophilic molecules and ions, thereby maintaining central nervous system homeostasis while limiting CNS penetration of many small‑molecule therapeutics. Claudin‑5 levels are actively regulated by growth and inflammatory signals, and its downregulation or junctional remodeling in neuroinflammatory and neurodegenerative settings increases permeability and facilitates immune and humoral access, whereas reinforcement of Claudin‑5 expression in brain endothelial cells reduces paracellular leak and can attenuate lung cancer cell invasion across the endothelium, implicating Claudin‑5‑dependent barrier integrity in the control of brain metastasis. Altered Claudin‑5 expression correlates with grade, stage, and metastatic propensity in multiple carcinomas, and both loss and overexpression have been associated with poor prognosis depending on tissue context.
    References
    • https://pubmed.ncbi.nlm.nih.gov/30691500/
    • https://pubmed.ncbi.nlm.nih.gov/28961379/

    Tech Support

    Handling Instructions

    Tel: +1-832-582-8158 Ext:3

    If you have any other enquiries, please leave a message.